Polymorphisms in the Hsp70 gene locus are genetically associated with systemic lupus erythematosus. Ann Rheum Dis

Nikolaus-Fiebiger Centre of Molecular Medicine, University of Erlangen-Nuremberg, Germany.
Annals of the rheumatic diseases (Impact Factor: 10.38). 05/2010; 69(11):1983-9. DOI: 10.1136/ard.2009.122630
Source: PubMed


Heat shock proteins (Hsps) play a role in the delivery and presentation of antigenic peptides and are thought to be involved in the pathogenesis of multifactorial diseases.
To investigate genes encoding cytosolic Hsp70 proteins for associations of allelic variants with systemic lupus erythematosus (SLE).
Case-control studies of two independent Caucasian SLE cohorts were performed. In a haplotype-tagging single-nucleotide polymorphism approach, common variants of HspA1L, HspA1A and HspA1B were genotyped and principal component analyses were performed for the cohort from the Oklahoma Medical Research Foundation (OMRF). Relative quantification of mRNA was carried out for each Hsp70 gene in healthy controls. Conditional regression analysis was performed to determine if allelic variants in Hsp70 act independently of HLA-DR3.
On analysis of common genetic variants of HspA1L, HspA1A and HspA1B, a haplotype significantly associated with SLE in the Erlangen-SLE cohort was identified, which was confirmed in the OMRF cohort. Depending on the cohorts, OR ranging from 1.43 to 1.88 and 2.64 to 3.16 was observed for individuals heterozygous and homozygous for the associated haplotype, respectively. Patients carrying the risk haplotype or the risk allele more often displayed autoantibodies to Ro and La in both cohorts. In healthy controls bearing this haplotype, the amount of HspA1A mRNA was significantly increased, whereas total Hsp70 protein concentration was not altered.
Allelic variants of the Hsp70 genes are significantly associated with SLE in Caucasians, independently of HLA-DR3, and correlate with the presence of autoantibodies to Ro and La. Hence, the Hsp70 gene locus appears to be involved in SLE pathogenesis.

Download full-text


Available from: Barbara Fuernrohr, Oct 05, 2015
44 Reads
  • Source
    • "Cerebrospinal fluid samples can be readily collected and analyzed over time, with inhibition of hsp70 secretory release being the ultimate test of ehsp70's role as a mediator versus marker of SRMA-associated inflammation. If hsp70 ultimately proves to be a mediator of inflammation in SRMA, then the genetic basis for variability in hsp70 expression demonstrated in humans (Maugeri et al., 2010) may contribute to breed predilections in development of SRMA (Tipold and Jaggy, 1994; Behr and Cauzinille, 2006; Wilbe et al., 2009), further substantiating the proposed role of hsp70 in other autoimmune conditions (Furnrohr et al., 2010). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The role of extracellular 70 kDa heat shock protein 70 (ehsp70) in central nervous system inflammation is vastly understudied, despite evidence supporting the ability to drive a pro-inflammatory state. We investigated the presence of ehsp70 in cerebrospinal fluid (CSF) and serum of dogs with Steroid Responsive Meningitis-Arteritis (SRMA), with the hypothesis that an ehsp70 response would occur, and might play a role in the pathogenesis of this disease. Samples from 30 dogs acutely affected with SRMA, and 30 dogs treated with corticosteroids and currently in clinical remission from SRMA were compared with normal dogs. Serum and CSF concentrations of ehsp70 were quantified using an enzyme-linked immunosorbent assay. An ehsp70 response occurred in the CSF of dogs with SRMA and this response was attenuated by corticosteroid treatment. There was no correlation between serum and CSF concentrations of ehsp70, supporting local production and release of ehsp70 and not simply leakage from serum. Dogs with SRMA thus represent a powerful spontaneous model by which to study the role of ehsp70 in CNS inflammation.
    Veterinary Immunology and Immunopathology 11/2011; 145(1-2):129-33. DOI:10.1016/j.vetimm.2011.10.021 · 1.54 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: We have performed neutron scattering experiments to investigate the static magnetic structure and the magnetic critical scattering in the three-dimensional percolating Heisenberg antiferromagnet, RbMn0.31Mg0.69F3, whose magnetic concentration is just at the percolation concentration for a cubic lattice, cP=0.312. Magnetic scattering was observed around the superlattice point, (12,12,12). We determined the Néel temperature of this system to be TN=4.0±0.5K, and found that the critical scattering above TN is similar to that observed in the homogeneous system. At T=1.6K well below TN, the scattering function is described by a sum of the critical scattering and elastic scattering components, and we demonstrated that the q-variation of the intensity of the elastic scattering component can be described using the fractal dimension.
    Physica B Condensed Matter 11/2006; 385:441-443. DOI:10.1016/j.physb.2006.05.146 · 1.32 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Numerous genes/SNPs in autoimmune diseases (ADs) are identified through genome-wide association studies (GWAS) and likely to contribute in developing autoimmune phenotypes. Constructions of biologically meaningful pathways are necessary to determine how these genes interact with each other and with other small molecules to develop various complex AD phenotypes prior to beginning time-consuming rigorous experimentation. We have constructed biological pathways with genetically identified genes leading to shared AD phenotypes. Various environmental and endogenous factors interact with these AD associated genes suggesting their critical role in developing diseases and further association studies could be designed for assessing the role of these factors with risk allele in a specific gene. Additionally, existing drugs that have been used long before the identification of these genetically associated genes also interact with these newly associated genes. Thus advanced therapeutic strategies could be designed by grouping patients with risk allele(s) in particular genes that directly or closely interact with the specified drugs. This drug-susceptible gene network will not only increase our understanding about the additional molecular basis for effectiveness against these diseases but also indicate which drug could be more effective for those patients carrying risk allele(s) in that gene. Additionally, we have also identified several interlinking genes in the pathways that could be used for designing future association studies.
    Autoimmunity reviews 01/2012; 12(4). DOI:10.1016/j.autrev.2012.09.001 · 7.93 Impact Factor
Show more